A Phase 3, Randomized, Double-Blind, Active Comparator Study of the Efficacy and Safety of R-TPR-015 (1422015) in Patients With Active Rheumatoid Arthritis on stable dose of Methotrexate.
Phase of Trial: Phase III
Latest Information Update: 21 Jan 2019
Price : $35 *
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors EPIRUS Biopharmaceuticals; Reliance Life Sciences
- 13 Jun 2015 Results (Secondary Efficacy Outcomes )presented at the 16th Annual Congress of the European League Against Rheumatism.
- 13 Jun 2015 Pooled safety data from this trial and a phase 1 trial in male volunteers presented at the 16th Annual Congress of the European League Against Rheumatism.
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History